
Update Profile / Unsubscribe
Our new pick is PMCB - Pharmacyte Biotech
---------------------------------------------------------------------------------------------------------------
Good Morning Readers And Welcome New Subscribers!
PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary
...read more
Stocks covered:
|
Compensation:
|
Avg $ Volume for Period:
|
PMCB
|
$2,000
|
UNKNOWN
|
Max Profit: 1.32 %
|
Gain at close: Pending
|